GO:0010961 intracellular magnesium ion homeostasis: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010961 intracellular magnesium ion homeostasis describes the biological process that maintains a steady-state level of magnesium ions (Mg2+) inside a cell.
• Magnesium is the second most abundant intracellular cation and is essential for ATP-dependent reactions, nucleic acid stability, and enzyme catalysis.
• Intracellular Mg2+ homeostasis is achieved through a balance of transport across the plasma membrane and intracellular buffering and compartmentalization.
• Disruption of intracellular magnesium homeostasis is linked to metabolic, cardiovascular, neurological, and liver diseases.
• Key molecular players include Mg2+ transporters and channels such as TRPM6, TRPM7, SLC41A1, and CNNM proteins.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of genes controlling intracellular magnesium homeostasis.
Description
Intracellular magnesium ion homeostasis (GO:0010961) is the biological process that maintains a steady-state concentration of magnesium ions within a cell. Magnesium is the second most abundant intracellular cation and serves as a cofactor for more than 600 enzymes, including all ATP-utilizing enzymes, and is critical for DNA and RNA stability. Because magnesium is involved in virtually every major cellular process, its intracellular concentration must be tightly controlled. The QuickGO definition states that this process is involved in the maintenance of a steady state level of magnesium ions within a cell. Researchers study GO:0010961 to understand how cells regulate magnesium uptake, efflux, buffering, and compartmentalization, and how defects in these mechanisms contribute to disease. The process is distinct from systemic magnesium homeostasis, which involves intestinal absorption and renal excretion. This article provides a research-grade overview of the ontology term, its molecular players, its role in disease, and the experimental methods used to investigate it.
intracellular magnesium ion homeostasis At A Glance
| GO ID | GO:0010961 |
|---|---|
| GO term | intracellular magnesium ion homeostasis |
| Ontology | biological_process |
| Synonym | cellular magnesium ion homeostasis |
| Definition | A homeostatic process involved in the maintenance of a steady state level of magnesium ions within a cell. |
| Major function | Maintains intracellular Mg2+ concentration for enzyme catalysis, ATP utilization, and nucleic acid stability. |
| Key transporters | TRPM6, TRPM7, SLC41A1, CNNM2, CNNM4, MAGT1 |
| Associated diseases | Hypomagnesemia, cardiovascular disease, diabetes, liver disease, neurological disorders |
| Research methods | CRISPR knockout, knock-in, overexpression, fluorescent Mg2+ imaging, electrophysiology, RNA-seq |
What Is GO:0010961?
GO:0010961 intracellular magnesium ion homeostasis is defined as a homeostatic process involved in the maintenance of a steady state level of magnesium ions within a cell. In other words, it encompasses all cellular mechanisms that sense, buffer, transport, and regulate Mg2+ so that its cytosolic and organellar concentrations remain within a narrow physiological range despite fluctuations in extracellular magnesium availability. This process includes Mg2+ influx and efflux across the plasma membrane, intracellular buffering by ATP and other chelators, and sequestration into or release from organelles such as mitochondria and the endoplasmic reticulum.
Why Is intracellular magnesium ion homeostasis Important in Cell Biology?
Intracellular magnesium ion homeostasis is fundamental because Mg2+ is required for ATP-dependent reactions, nucleic acid stability, and the activity of hundreds of enzymes. Perturbations in this process are associated with a wide range of human diseases, including cardiovascular disorders, diabetes, and liver disease. Understanding GO:0010961 therefore provides mechanistic insight into how cells adapt to magnesium stress and how dysregulation contributes to pathology.
• Mg2+ is a cofactor for over 600 enzymes, including all ATP-utilizing enzymes.
• Intracellular Mg2+ stabilizes DNA and RNA structures and is required for ribosome function.
• Dysregulation of Mg2+ homeostasis is linked to cardiovascular disease, including hypertension and arrhythmias.
• Magnesium imbalance contributes to insulin resistance and diabetes.
• Liver diseases are associated with altered magnesium homeostasis, suggesting therapeutic potential.
• Neurological disorders may involve disturbed intracellular Mg2+ regulation.
• Mg2+ transport proteins such as TRPM6 and TRPM7 are critical for cellular Mg2+ uptake.
• Heart failure management includes monitoring electrolyte homeostasis, including magnesium.
• Electrolyte disorders, including magnesium, are common in clinical practice.
• Cattle models provide insights into systemic magnesium homeostasis relevant to agriculture.
What Happens During intracellular magnesium ion homeostasis?
Magnesium influx across the plasma membrane
In simple terms: Cells take in magnesium from the outside through specialized channel proteins.
Intracellular magnesium homeostasis begins with the uptake of Mg2+ from the extracellular space. This is mediated by transport proteins such as TRPM6 and TRPM7, which form ion channels permeable to Mg2+. TRPM7 is a ubiquitously expressed channel-kinase, while TRPM6 is predominantly found in the kidney and intestine, where it plays a key role in active Mg2+ absorption. SLC41A1 is another plasma membrane transporter that facilitates Mg2+ influx. The activity of these transporters is regulated by intracellular Mg2+ levels and by hormonal signals, ensuring that cells acquire sufficient Mg2+ without toxic overload.
Intracellular buffering and chelation
In simple terms: Inside the cell, magnesium is bound by molecules like ATP so it does not float freely.
Once inside the cell, a large fraction of Mg2+ is buffered by ATP, ADP, GTP, and other nucleotides, as well as by proteins and nucleic acids. This buffering maintains the free Mg2+ concentration in the cytosol at a relatively low level (around 0.5-1 mM), while total cellular magnesium can be much higher. The buffering capacity is dynamic and can change in response to metabolic state, because ATP levels fluctuate with cellular energy demand. This chelation prevents precipitation of magnesium-phosphate complexes and ensures that Mg2+ is available for enzymatic reactions when needed.
Organellar sequestration and release
In simple terms: Cells store magnesium in compartments like mitochondria and release it when needed.
Intracellular Mg2+ is also compartmentalized into organelles such as mitochondria, the endoplasmic reticulum, and the nucleus. Mitochondria accumulate Mg2+ through the mitochondrial RNA splicing 2 (MRS2) transporter and can release it via the mitochondrial Mg2+ efflux system. This organellar sequestration serves as a buffer to maintain cytosolic Mg2+ levels and also provides Mg2+ for mitochondrial ATP synthesis. The endoplasmic reticulum and Golgi apparatus also store Mg2+ and contribute to its intracellular distribution.
Magnesium efflux and excretion
In simple terms: Cells get rid of excess magnesium through export proteins.
To prevent toxic accumulation, cells export Mg2+ across the plasma membrane. This is mediated by transporters such as SLC41A1 and CNNM proteins (CNNM2, CNNM4), which function as Na+/Mg2+ exchangers or Mg2+ efflux channels. In the kidney, CNNM2 is critical for renal Mg2+ reabsorption, and mutations in CNNM2 cause hypomagnesemia. The coordinated regulation of influx and efflux ensures that intracellular Mg2+ remains within a narrow physiological range.
Regulation by hormones and signaling pathways
In simple terms: Hormones and signaling molecules tell cells when to take up or release magnesium.
Intracellular magnesium homeostasis is regulated by hormonal and signaling pathways. For example, insulin and IGF-1 can stimulate Mg2+ uptake, while catecholamines may promote efflux. The epidermal growth factor (EGF) signaling pathway regulates TRPM6 activity, and mutations in EGF cause hypomagnesemia with secondary hypocalcemia. Additionally, the mTOR pathway has been implicated in sensing Mg2+ levels and modulating transport activity. These regulatory mechanisms allow cells to adapt to changing physiological conditions.
Key Genes Involved in GO:0010961 intracellular magnesium ion homeostasis
The following genes encode proteins that directly participate in or regulate intracellular magnesium ion homeostasis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRPM6 | Mg2+ channel in kidney and intestine | Mutations cause hypomagnesemia with secondary hypocalcemia |
| TRPM7 | Ubiquitous Mg2+ channel-kinase | Essential for cellular Mg2+ uptake and cell viability |
| SLC41A1 | Na+/Mg2+ exchanger | Linked to hypertension and Mg2+ efflux |
| CNNM2 | Mg2+ efflux transporter in kidney | Mutations cause renal hypomagnesemia |
| CNNM4 | Mg2+ transporter in intestine | Mutations cause Jalili syndrome |
| MAGT1 | Mg2+ transporter in T cells | Defects cause immunodeficiency |
| MRS2 | Mitochondrial Mg2+ transporter | Regulates mitochondrial Mg2+ and energy metabolism |
| NIPA1 | Mg2+ transporter in neurons | Associated with spastic paraplegia |
| NIPA2 | Mg2+ transporter | May regulate neuronal Mg2+ homeostasis |
| MMGT1 | Golgi Mg2+ transporter | Involved in secretory pathway Mg2+ handling |
| ATP1A1 | Na+/K+ ATPase | Indirectly affects Mg2+ homeostasis via membrane potential |
| EGF | Growth factor regulating TRPM6 | Mutations cause hypomagnesemia |
| CLDN16 | Tight junction protein | Regulates paracellular Mg2+ reabsorption |
| CLDN19 | Tight junction protein | Mutations cause hypomagnesemia |
| KCNA1 | Potassium channel | May influence Mg2+ transport |
| SLC41A2 | Mg2+ transporter | Potential role in Mg2+ homeostasis |
| TRPM7 | Mg2+ channel-kinase | Regulates cell growth and proliferation |
How Is intracellular magnesium ion homeostasis Regulated?
Intracellular magnesium ion homeostasis is regulated at multiple levels. Hormonal signals such as insulin, IGF-1, and EGF modulate the activity of Mg2+ transporters like TRPM6. The mTOR signaling pathway has been implicated in sensing Mg2+ availability and regulating transport. Additionally, intracellular Mg2+ levels themselves feedback on transporter activity, and changes in ATP/ADP ratios affect Mg2+ buffering. In the kidney, parathyroid hormone and aldosterone influence renal Mg2+ reabsorption, indirectly affecting intracellular homeostasis.
intracellular magnesium ion homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRPM6 | Hypomagnesemia with secondary hypocalcemia | Knockout mouse, patient-derived iPSCs |
| CNNM2 | Renal hypomagnesemia | Knockout zebrafish, HEK293 knockout |
| MAGT1 | Immunodeficiency with Mg2+ defect | T cell knockout, Jurkat cells |
| SLC41A1 | Hypertension, Mg2+ imbalance | Knockout rat, vascular smooth muscle cells |
| MRS2 | Mitochondrial dysfunction | Knockout HeLa, mitochondrial Mg2+ imaging |
Cardiovascular disease
Magnesium imbalance is associated with hypertension, arrhythmias, and heart failure. Low intracellular Mg2+ can promote vasoconstriction and cardiac arrhythmias, while supplementation may be beneficial. In heart failure, decongestion strategies must consider electrolyte homeostasis, including magnesium.
Metabolic disorders and diabetes
Magnesium plays a key role in glucose homeostasis, and hypomagnesemia is common in type 2 diabetes. Insulin resistance is linked to decreased intracellular Mg2+, and magnesium supplementation may improve insulin sensitivity.
Liver disease
Targeting magnesium homeostasis has emerged as a novel therapeutic strategy for liver diseases, including non-alcoholic fatty liver disease and hepatocellular carcinoma. Dysregulated Mg2+ transport affects hepatocyte function and proliferation.
Neurological and renal disorders
Mutations in Mg2+ transporters cause hypomagnesemia with secondary hypocalcemia (TRPM6), renal hypomagnesemia (CNNM2), and spastic paraplegia (NIPA1). These disorders highlight the importance of intracellular Mg2+ homeostasis in neuronal and renal function.
From intracellular magnesium ion homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TRPM6 mediate Mg2+ influx? | TRPM6 knockout HEK293 cells |
| What is the role of CNNM2 in renal Mg2+ reabsorption? | CNNM2 knockout mouse |
| How does SLC41A1 affect blood pressure? | SLC41A1 knockout rat |
| Does MAGT1 regulate T cell activation? | MAGT1 knockout Jurkat cells |
| Can overexpression of MRS2 rescue mitochondrial Mg2+? | MRS2 overexpression in HeLa cells |
| What is the effect of point mutation in TRPM7 on channel activity? | TRPM7 point-mutant knock-in cells |
How to Study the intracellular magnesium ion homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent Mg2+ imaging | Intracellular free Mg2+ concentration | Live-cell monitoring of Mg2+ dynamics |
| Patch-clamp | Mg2+ currents through channels | Characterization of TRPM6/7 activity |
| CRISPR knockout screen | Genes required for Mg2+ homeostasis | Identification of novel regulators |
| RNA-seq | Transcriptional changes | Response to Mg2+ stress |
| Proteomics | Protein abundance and modifications | Pathway analysis |
| Atomic absorption spectroscopy | Total cellular Mg2+ content | Quantification of Mg2+ levels |
| Inductively coupled plasma mass spectrometry | Trace element quantification | Measurement of Mg2+ isotopes |
Fluorescent Mg2+ imaging
Fluorescent dyes such as Mag-Fura-2 and Mag-Fluo-4 allow real-time measurement of intracellular Mg2+ concentrations in live cells. These dyes are ratiometric and can be used to monitor changes in cytosolic or organellar Mg2+ in response to stimuli.
Electrophysiology
Patch-clamp recordings can measure Mg2+ currents through channels such as TRPM6 and TRPM7. This technique provides direct evidence of channel activity and regulation by intracellular Mg2+.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes essential for intracellular Mg2+ homeostasis. Cells are challenged with low or high Mg2+ conditions, and sgRNA enrichment or depletion is measured by sequencing.
RNA-seq and proteomics
Transcriptomic and proteomic profiling reveal changes in gene expression and protein abundance in response to altered Mg2+ levels. These methods help identify regulatory networks and biomarkers of Mg2+ imbalance.
How CRISPR Can Be Used to Study GO:0010961 intracellular magnesium ion homeostasis
Knockout
CRISPR knockout of genes such as TRPM6, TRPM7, or CNNM2 can abolish Mg2+ transport and reveal their essential roles in intracellular homeostasis. Knockout cell lines are valuable for studying compensatory mechanisms and for drug screening.
Point Mutation
Introducing disease-associated point mutations (e.g., in TRPM6 or CNNM2) using CRISPR base editing or homology-directed repair allows functional analysis of specific variants. These models help determine whether a mutation is causal or a benign polymorphism.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci (e.g., TRPM7-GFP) enables real-time imaging and proteomic analysis of Mg2+ transporters. This approach preserves native regulation and expression levels.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of Mg2+ transporters can increase intracellular Mg2+ uptake and protect against Mg2+ deficiency. Overexpression models are useful for gain-of-function studies and for testing therapeutic candidates.
How EDITGENE Supports intracellular magnesium ion homeostasis Research
Researchers studying intracellular magnesium ion homeostasis-related genes often need to determine whether a candidate gene is causally involved in Mg2+ regulation or is merely correlated with changes in cellular Mg2+ levels. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from knockout to precise point mutations and overexpression.
Contact EDITGENE today to design your custom CRISPR model for intracellular magnesium ion homeostasis research.
Frequently Asked Questions About intracellular magnesium ion homeostasis
What is intracellular magnesium ion homeostasis?
Intracellular magnesium ion homeostasis (GO:0010961) is the biological process that maintains a steady-state level of magnesium ions within a cell, involving transport, buffering, and compartmentalization.
What genes are involved in intracellular magnesium ion homeostasis?
Key genes include TRPM6, TRPM7, SLC41A1, CNNM2, CNNM4, MAGT1, and MRS2, which encode Mg2+ transporters and channels.
Why is magnesium important for cells?
Magnesium is a cofactor for over 600 enzymes, including all ATP-utilizing enzymes, and is essential for DNA and RNA stability.
What diseases are linked to magnesium homeostasis?
Diseases include hypomagnesemia, cardiovascular disease, diabetes, liver disease, and neurological disorders.
How is intracellular magnesium measured?
Fluorescent dyes such as Mag-Fura-2 and Mag-Fluo-4, patch-clamp electrophysiology, and atomic absorption spectroscopy are commonly used.
What is the role of TRPM6 in magnesium homeostasis?
TRPM6 is a Mg2+ channel in the kidney and intestine; mutations cause hypomagnesemia with secondary hypocalcemia.
Can CRISPR be used to study magnesium transporters?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to study Mg2+ transporter function.
What is the difference between systemic and intracellular magnesium homeostasis?
Systemic homeostasis involves intestinal absorption and renal excretion, while intracellular homeostasis focuses on maintaining Mg2+ levels within cells.
How does magnesium affect glucose homeostasis?
Magnesium plays a key role in insulin signaling and glucose metabolism; hypomagnesemia is common in type 2 diabetes.
What are the symptoms of magnesium deficiency?
Symptoms include muscle cramps, arrhythmias, and metabolic disturbances; severe deficiency can affect cardiovascular and neurological function.
Conclusion
Intracellular magnesium ion homeostasis (GO:0010961) is a fundamental biological process that maintains the proper concentration of Mg2+ within cells, supporting countless enzymatic reactions and cellular functions. Dysregulation of this process is implicated in a wide range of diseases, from cardiovascular disorders to diabetes and liver disease. Advances in CRISPR-based gene editing and imaging technologies are enabling researchers to dissect the molecular mechanisms of Mg2+ transport and regulation with unprecedented precision. Continued research into GO:0010961 promises to uncover new therapeutic targets for diseases associated with magnesium imbalance.
References
- 1. de Baaij JH et al.. 2015. Magnesium in man: implications for health and disease.. Physiol Rev 95(1):1-46 PMID: 25540137
- 2. Vink R et al.. 2011. Intracellular magnesium homeostasis.. PMID: 29920012
- 3. Van den Eynde J et al.. 2025. Water and electrolyte homeostasis during decongestion in heart failure.. Eur J Heart Fail 27(12):3072-3083 PMID: 40530753
- 4. Shrimanker I et al.. 2026. Electrolytes.. PMID: 31082167
- 5. Paolisso G et al.. 1990. Magnesium and glucose homeostasis.. Diabetologia 33(9):511-4 PMID: 2253826
- 6. Ji L et al.. 2026. Targeting magnesium homeostasis: a novel therapeutic strategy for liver diseases.. Front Nutr 13:1709477 PMID: 41859661
- 7. Tangvoraphonkchai K et al.. 2018. Magnesium and Cardiovascular Disease.. Adv Chronic Kidney Dis 25(3):251-260 PMID: 29793664
- 8. Martens H et al.. 2018. Magnesium homeostasis in cattle: absorption and excretion.. Nutr Res Rev 31(1):114-130 PMID: 29318981
